Dictionary

allow_url_fopen is ENABLED Dictionary Search

dmd [Palindrome]

Synonyms

Noun

1. Doctor of Dental Medicine

2. DMD, doctor's degree, doctorate

Usage
Skeletal-muscle-targeted non-viral delivery of full-length DMD mRNA for Duchenne muscular dystrophy - Nature
Satellos wins FDA Fast Track for Duchenne drug SAT-3247 - Stock Titan
Capricor thrown for another loop as FDA sets adcomm for DMD cardiomyopathy therapy - BioSpace
Japan's Nippon Shinyaku partners with Elixirgen to develop drug for Duchenne Muscular Dystrophy treatment - BioSpectrum Asia
Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference - Yahoo Finance
Elixirgen and Nippon Shinyaku ink option agreement on DMD - The Pharma Letter
DMD Treatment Algorithms: Initiating and Sequencing Therapies in New Patients - NeurologyLive
Can Satellos Deliver On The Promise Of SAT-3247 In DMD? - RTTNews
New mRNA Delivery Platform Restores Muscle Function in DMD Models - Genetic Engineering and Biotechnology News
RGX-202 gene therapy meets main goal in Phase 3 DMD clinical trial - Muscular Dystrophy News
Capricor’s Positive 5-Year Data For DMD Treatment Comes With A Regulatory Catch – CAPR Stock Slides 11% - Stocktwits
Capricor Therapeutics Announces FDA Advisory Committee - GlobeNewswire
Novel gene therapy platform restores muscle function in models of Duchenne muscular dystrophy - UT MD Anderson
FDA schedules advisory meeting for Capricor’s DMD therapy - Investing.com
Emerging Therapies in DMD - NeurologyLive
Disease exacerbation in human DMD MYOrganoids enables gene therapy evaluation and unveils persistence of fibrotic activity - Nature
Capricor's Duchenne drug shows 5-year muscle and heart data at PPMD - Stock Titan
Conditional Dmd ablation in muscle and brain causes profound effects on muscle function and neurobehavior - Nature
FDA Fast Track boosts Satellos (NASDAQ: MSLE) SAT-3247 Duchenne program - Stock Titan
Multidisciplinary Care and Recent Advances in DMD - NeurologyLive
REGENXBIO to push for accelerated approval of DMD gene therapy - Clinical Trials Arena
Can Viltolarsen Treat DMD? - Docwire News
Durwood Alfred “Danny” Nowell, Jr. D.M.D. - Rickey Stokes News
FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy - Contemporary Pediatrics
Stable heart health seen long-term for women with BMD, DMD mutations - Muscular Dystrophy News
Unmet Needs and Emerging Horizons for DMD - NeurologyLive
FDA Clears ARCUS Editor for Duchenne Hot-spot - CRISPR Medicine News
Nippon Shinyaku and Elixirgen Therapeutics Enter Option Agreement for Development and Commercialization of EXG-7001 for Duchenne Muscular Dystrophy - PR Newswire
European regulators back new DMD gene therapy with key status - Muscular Dystrophy News
FDA clears trial testing Mesoblast cell therapy in kids with DMD - Muscular Dystrophy News
Can SAT-3247 Treat DMD? - Docwire News
Capricor to Present Positive Five-Year HOPE-2 OLE Data and - GlobeNewswire
When it comes to raising a child with DMD, the third time is not the charm - Muscular Dystrophy News
Tooth Talk: Q&A with Lesly Joseph DMD AS 27 - Boston University
‘Heart-on-a-chip’ project to help researchers study BMD, DMD - Muscular Dystrophy News
Novel Digital Measures for Tracking Disease Progression in Duchenne Muscular Dystrophy Beyond Loss of Ambulation - NeurologyLive
Regenxbio: 'Strong Buy' On FDA Course Reversal For NAVSUNLI And Potential AA DMD Filing - Seeking Alpha
Regenxbio reaps pivotal win for Duchenne muscular dystrophy gene therapy - Fierce Biotech
Global trial testing Dyne’s Z-rostudirsen for boys with DMD now underway - Muscular Dystrophy News
Durwood Alfred “Danny” Nowell, Jr. D.M.D. - Rickey Stokes News
MDA 2026: Dyne advances DMD therapy z-rostudirsen toward approval - Muscular Dystrophy News
DMD acquires ITAD firm Lifespan, outlines acquisition strategy - Resource Recycling
EU panel recommends expanded use of DMD treatment Agamree - Muscular Dystrophy News
Entrada’s stock drops as DMD drug’s efficacy falls short - Clinical Trials Arena
Advocates say 2026 will be ‘an exciting time’ for DMD community - Muscular Dystrophy News
MDA 2026: Duvyzat shows DMD benefits even at lower dose levels - Muscular Dystrophy News
Entrada's stock craters as DMD data underperform expectations, handing advantage to Novartis - Fierce Biotech
StockWatch: Regenxbio Tumbles Despite Positive Pivotal Data for DMD Gene Therapy Candidate - Genetic Engineering and Biotechnology News
MDA 2026: SGT-003 gene therapy shows early promise for DMD in trial - Muscular Dystrophy News
Capricor’s DMD Cardiomyopathy Cell Therapy Deramiocel Back Under Review by FDA - NeurologyLive
Inspired by son, Anning offers forward-thinking approach to muscular dystrophy care - Slippery Rock University
Precision gains FDA approval to begin Phase I/II FUNCTION-DMD trial - Clinical Trials Arena
DMD Awareness Week: Duchenne Candidates to Watch in 2026 - NeurologyLive
First boys dosed in Phase 2 trial of oral DMD treatment SAT-3247 - Muscular Dystrophy News
Capricor Therapeutics (CAPR) Is Down 6.8% After Positive Five-Year HOPE-2 DMD Data And FDA Update - simplywall.st
DMD Case Study: Treatment Decisions, and Managing Multisystem Complications - NeurologyLive
Trial testing gene-editing therapy PBGENE-DMD gets FDA green light - Muscular Dystrophy News
Roche Ends SHIELD DMD Trial as Recruitment Challenges Intensify - BioPharm International
Brogidirsen Demonstrates Long-Term Safety and Stable Motor Function in DMD - NeurologyLive
Starting corticosteroids earlier helps improve motor function in DMD - Muscular Dystrophy News
DMD Treatment Changes: Combination Therapy, Adherence, and Gene Therapy Access - NeurologyLive
Patients Treated With Regenxbio’s DMD Gene Therapy RGX-202 Exceed Expected Disease Trajectory on NSAA - NeurologyLive
MDA 2026: FDA decision on deramiocel for DMD expected by August - Muscular Dystrophy News
DMD gene therapy can repair muscle fibers but fails to halt tissue scarring - Muscular Dystrophy News
Cell Therapy Deramiocel Meets Primary End Point in Phase 3 DMD Cardiomyopathy Trial - NeurologyLive
Novel gene therapy platform restores muscle function in Duchenne muscular dystrophy model - Medical Xpress
Following Sarepta Woes, Others Look To Unlock the Next Chapter in DMD Treatment - BioSpace
DMD Gene Therapy Elevidys Shows Functional Benefit at 2 Years in Phase 3 EMBARK Trial - NeurologyLive
Charles A. Beck Jr., C’71, DMD, Scholars Program to aid future Saint Vincent pre-dental students - Saint Vincent College
Parkin overexpression attenuates muscle atrophy and improves mitochondrial bioenergetics but not histological features of Duchenne muscular dystrophy in mice - Nature
FDA grants rare pediatric designation to (Z)-Endoxifen for DMD - Muscular Dystrophy News
Wicker Applauds HHS DMD Announcement - Senator Roger Wicker (.gov)
Regenxbio eyes 2027 launch for DMD gene therapy, but investors wary - FirstWord Pharma
In my life with DMD, I want to keep paying it forward, one story at a time - Muscular Dystrophy News
Does DMD start in the womb? New research challenges old beliefs. - Muscular Dystrophy News
Impaired stem cell migration and divisions in Duchenne muscular dystrophy revealed by live imaging - Nature
Regenxbio pads DMD gene therapy's profile ahead of pivotal readout - FirstWord Pharma
Precision begins patient enrolment for FUNCTION-DMD trial - Clinical Trials Arena
Real-world experience with gene therapy in Duchenne muscular dystrophy center readiness and patients safety: report from Qatar - Nature
Roche halts development of satralizumab for DMD bone health - Muscular Dystrophy News
3-drug cocktail boosts DMD gene therapy effectiveness in mice - Muscular Dystrophy News
Development of a cost-effectiveness analysis model for Duchenne muscular dystrophy utilizing the national registry in Japan - Nature
When school is out, my sons with DMD get into their summer groove - Muscular Dystrophy News
Preclinical DMD gene therapy GB703 debuts as GEMMABio advances SMA program - Contemporary Pediatrics
DMD gene therapy leads to sustained benefits for 3 boys in trial - Muscular Dystrophy News
Faculty Spotlight: Shilpi Joshi DMD 12 Received Lucy Hobbs Project Humanitarian Award - Boston University
WVE-N531 Shows Sustained Dystrophin Production in Phase 2 Trial of Duchenne Muscular Dystrophy - NeurologyLive
Top 10 muscular dystrophy news stories of 2025 - Muscular Dystrophy News
Tooth Talk: Q&A with Alizah Tariq DMD 29 - Boston University
Impact of C4BPA on Muscle progenitor cell differentiation: insights for Duchenne muscular dystrophy treatment - Nature
Kobakhidze announces plans to procure DMD medication - OC Media
DMD Treatment Toolkit: Corticosteroids, Exon Skipping, and Gene Therapy - NeurologyLive
Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information - Sarepta Therapeutics
FDA Clears In-Vivo Gene Editing Therapy PBGENE-DMD for Duchenne Trial - BioPharm International
Entrada emphasises DMD therapy's safety as dystrophin data disappoint - FirstWord Pharma
DMD drugs show promise despite trial’s missing main goal: Sarepta - Muscular Dystrophy News
Spot Biosystems Launches with $40 Million Funding and Breakthrough Non-Viral Gene Therapy for DMD - bio-itworld.com
FDA Requests HOPE-3 Clinical Study Report for Deramiocel BLA in DMD Cardiomyopathy - NeurologyLive
Senior Exhibition and Film Festival Highlight DMD Capstone Projects - UConn Today
Nanoimprinted DMD Electrodes Enabling Bidirectional Viewing OLEDs With Quasi Lambertian Emission - Wiley & Sons
Foreign Language Equivalents
Foreign Language Equivalents of 'dmd'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
dnd,   fmd,   dd,   md,   mdd,   smd,   ddm,   dmdd,   dmmd,   dmf,   ddmd,   dms,   dm,   d,d
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z